Biological E collaborate with Bavarian Nordic to expand Chikungunya Vaccine access in low, middle income countries Ruchika Sharma1 March 2025 10:00 AM ISTHyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian Nordic's Chikungunya...
FDA Approves Vimkunya for prevention of Chikungunya Dr. Kamal Kant Kohli21 Feb 2025 8:30 AM ISTThe US Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya, a recombinant chikungunya vaccine, for individuals...
SII to manufacture Bavarian Nordic Mpox Vaccine Ruchika Sharma17 Dec 2024 12:30 PM ISTSII will be responsible for seeking and maintaining regulatory approval of the vaccine in India.
Bavarian Nordic sees potential to ramp up mpox vaccine capacity MD Bureau Team14 Sept 2024 9:15 AM ISTCopenhagen: Bavarian Nordic said on Thursday it could supply 13 million doses of its mpox vaccine by the end of 2025, up from a previous forecast...
Monkeypox: Bavarian Nordic Jynneos vaccine gets USFDA emergency use nod Ruchika Sharma11 Aug 2022 2:00 PM ISTFor those aged 18 years and older determined to be at high risk of monkeypox infection, the authorization allows for a fraction of the Jynneos dose to...
In talks with Bavarian Nordic for import of monkeypox vaccine: Serum institute CEO Ruchika Sharma27 July 2022 1:15 PM ISTBavarian Nordic has already developed a vaccine against monkeypox and is available in different markets under brand names Jynneos, Imvamune or...
Bavarian Nordic monkeypox vaccine gets preliminary nod from EU drug regulator Ruchika Sharma24 July 2022 1:45 PM ISTCopenhagen: Danish biotechnology company Bavarian Nordic said on Friday the European Union's drug regulator had recommended its Imvanex vaccine be...
EU regulator begins review of Bavarian Nordic smallpox vaccine Imvanex for monkeypox Ruchika Sharma29 Jun 2022 1:00 PM ISTMost monkeypox patients experience only fever, body aches, chills and fatigue.
